OptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Recommendation of Moderate Buy from Brokerages

OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the seven analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target among analysts that […]

Related Keywords

Hong Kong ,Canada ,Stifel Nicolaus ,Nisa Investment Advisors ,Royal Bank ,Optimizerx Corporation ,Nasdaq ,Optimizerx Company Profile ,Optimizerx Co ,Barclays ,Hong Kong Ltd ,Get Free Report ,Investment Advisors ,Financial Advisors ,Kong Ltd ,Get Free ,Evidence Based Physician Engagement ,Care Banner ,Optimizerx Daily ,Optimizerx ,Nasdaq Oprx ,Oprx ,Computer And Technology ,Ratings ,Consensus ,